Over 100 Comments Already Submitted on DEA’s Marijuana Rescheduling Decision: Here’s How to View Them

Earlier today, the Drug Enforcement Administration (DEA) officially published in the Federal Register its proposal to reschedule marijuana, kicking off the legally required 60-day public comment period. Within hours, over 100 comments have already been submitted.

The DEA’s proposal would move marijuana from its current classification as a Schedule I drug under the Controlled Substances Act to a Schedule III substance. This change would greatly ease access to marijuana research, legalize marijuana compounds for medical use nationwide, and provide medical marijuana patients and businesses in states where it’s legal a range of federal protections.

Today’s publication in the Federal Register gives the public until July 22 to provide comments, sharing their opinions and suggestions. Following the public comment period, the DEA will review all submissions to assess public opinion. This process will culminate in a final hearing and the issuance of a final ruling.

All of the comments provided to the DEA are a matter of public record and can be viewed here. As of nearly 11am PT, over 100 comments have already been submitted. The vast majority of these comments are either in support of rescheduling marijuana or advocating for the DEA to go further and deschedule it altogether. Only a few suggest that the DEA retain marijuana as a Schedule I drug.

Thomas Bogg commented, “Finally some good legislation. It’s time to stop treating using a plant with many medicinal uses as a criminal action. This is good for the USA.”

Andrew Stammworthy said, “I fully support the rescheduling of marijuana to a lower level. I believe the legalization efforts across the country and frequent use by a large section of the population show that the original classification was a mistake.”

Many of the comments urged the DEA to fully deschedule marijuana. Megan Diamondstein stated, “Rescheduling cannabis from Schedule I to Schedule III, as the Department of Health & Human Services and the DEA have proposed, is insufficient. If cannabis remains on the CSA, people can continue to face penalties at the federal level for possession, including arrest and incarceration, which lead to a lifetime of consequences that impact someone’s ability to secure employment, housing, public benefits, educational opportunities, and more.”

She added, “The criminalization of cannabis—a legacy of the War on Drugs—was a policy decision rooted in racism. In the decades since, its enforcement has been disproportionately targeted at Black people and other people of color. It’s time to abandon this draconian approach. I support descheduling cannabis from the CSA—a step toward righting the wrongs of its criminalization.”

Zach Newman shared a similar sentiment, saying, “While rescheduling cannabis as Schedule III would be a step forward, acknowledging it has medical uses, it should be completely descheduled. President Biden has said many times that no person should be in jail for cannabis, and simply rescheduling it continues its status of federal illegality.”

Christopher Bourg commented, “Rescheduling cannabis is a good first step. However, cannabis needs to be fully descheduled. Also, medical cannabis patients should not have to fear losing their careers over positive drug tests for past use of cannabis. Test for impairment only for safety-sensitive employees. No one should have to fear losing their careers over taking doctor-prescribed or recommended medication.”

To view more comments, click here.

Thank you for reading The Marijuana Herald! You can find more news stories by clicking here, and you can sign up for daily news updates by clicking here

 

 

 

More articles from The Marijuana Herald can be found below.

Ohio Now Has 186 Licensed Marijuana Stores, With 95 More in Provisional Status

Ohio Now Has 186 Licensed Marijuana Stores, With 95 More in Provisional Status

Florida Representative Files Bill to Tighten Medical Marijuana Rules and Expand Health Programs

Florida Representative Files Bill to Tighten Medical Marijuana Rules and Expand Health Programs

U.S. Senate Bill Would Create National Framework for Hemp-Derived Cannabinoids, Limit Products to 5mg THC Per Serving

U.S. Senate Bill Would Create National Framework for Hemp-Derived Cannabinoids, Limit Products to 5mg THC Per Serving

Florida GOP Lawmaker Files Bill to Expand Medical Marijuana Access, Increase Supply Limits, and Loosen Key Restrictions

Florida GOP Lawmaker Files Bill to Expand Medical Marijuana Access, Increase Supply Limits, and Loosen Key Restrictions

Connecticut Marijuana Sales Top $257 Million in 2025, Price Per Gram in November Drops Below $8 for First Time

Connecticut Marijuana Sales Top $257 Million in 2025, Price Per Gram in November Drops Below $8 for First Time

New Jersey Cannabis Commission to Hold Virtual Meetings on How Social Equity Excise Fee Dollars Should Be Spent

New Jersey Cannabis Commission to Hold Virtual Meetings on How Social Equity Excise Fee Dollars Should Be Spent

Ohio Senate Approves Bill to Overhaul State’s Marijuana Laws, Including Criminalizing Public Use and Establishing Hemp Restrictions

Ohio Senate Approves Bill to Overhaul State’s Marijuana Laws, Including Criminalizing Public Use and Establishing Hemp Restrictions

New Hampshire: Bipartisan Coalition of Lawmakers Introduce Constitutional Amendment to Guarantee Those 21+ the Right to Possess Marijuana

New Hampshire: Bipartisan Coalition of Lawmakers Introduce Constitutional Amendment to Guarantee Those 21+ the Right to Possess Marijuana

Cannabix Technologies’ Marijuana Breath Test Device Clears Key U.S. and Canadian Regulatory Hurdle

Cannabix Technologies’ Marijuana Breath Test Device Clears Key U.S. and Canadian Regulatory Hurdle

Cronos Group to Acquire Europe’s Largest Adult-Use Cannabis Company in $67 Million Deal

Cronos Group to Acquire Europe’s Largest Adult-Use Cannabis Company in $67 Million Deal

Minnesota’s “Open Package” Marijuana Law Has Fueled Thousands of New Charges Since Legalization

Minnesota’s “Open Package” Marijuana Law Has Fueled Thousands of New Charges Since Legalization

Montana Cannabis Sales Top $26 Million in November, Pushing Year-to-Date Total to $300 Million

Montana Cannabis Sales Top $26 Million in November, Pushing Year-to-Date Total to $300 Million

Safe Harbor Financial Announces “Major Banking Win” With Canopy HR, Launches New Cashflow Tool for Cannabis Businesses

Safe Harbor Financial Announces “Major Banking Win” With Canopy HR, Launches New Cashflow Tool for Cannabis Businesses

The Cheapest Legal Cannabis Prices as of December 2025: Oregon Leads, Followed Closely by Michigan and Massachusetts

The Cheapest Legal Cannabis Prices as of December 2025: Oregon Leads, Followed Closely by Michigan and Massachusetts

Florida Lawmaker Introduces Bill Shielding Employers From Civil Liability in Marijuana-Related Employment Actions

Florida Lawmaker Introduces Bill Shielding Employers From Civil Liability in Marijuana-Related Employment Actions

New Jersey Senate Committee Advances Bill Overhauling Cannabis Commission Rules and Expanding Dispensary Licensing

New Jersey Senate Committee Advances Bill Overhauling Cannabis Commission Rules and Expanding Dispensary Licensing

New York Governor Forces Out Cannabis Director Amid Enforcement Turmoil

New York Governor Forces Out Cannabis Director Amid Enforcement Turmoil

Study: Tailored Full-Spectrum Marijuana Extracts Linked to Broad Benefits for Women With Chronic Pain

Study: Tailored Full-Spectrum Marijuana Extracts Linked to Broad Benefits for Women With Chronic Pain